RiMS is seeking a new Chair for the rebranded Special Interest Group Patient Empowerment. This is a great opportunity to strengthen your leadership skills, expand your professional network, and shape the future of MS rehabilitation research.

The first scientific article from the German–Danish collaboration project “Kynurenine Pathway in MS (KP-MS)”, funded by the RiGra 2023 programme, has been published in Neurology® Neuroimmunology & Neuroinflammation.

The TEN4CARE (Tendon Engineering for Comprehensive Advanced Rehabilitation and Enhancement) Project has launched its official website! Have a look to learn more about this promising 48-month EU-funded Innovation Action under Grant Agreement No. 101178590.

RiMS is seeking four new Executive Board Members. This is an excellent opportunity to strengthen your leadership skills, expand your professional network, and actively contribute to the advancement of Multiple Sclerosis rehabilitation. Applications are open until Saturday, 31 January 2026. Learn more below about the role, timeline, and application process.

A new e-learning material is available! Watch the recording of our Neurowebinar in collaboration with ECTRIMS, exploring how Disease-Modifying Therapies (DMTs) and rehabilitation complement each other to slow disease progression, strengthen neurological reserve, and enhance quality of life.

If you live in Australia, Belgium, Czech Republic, Ireland, Italy, Greece, Serbia, United Kingdom, Spain or Israel, the RiMS SIG Mobility group invites you to take part in our limited-time international study on physical activity among people living with Multiple Sclerosis.